Divergent effects of the ‘biased’ 5‐HT1A receptor agonists F15599 and F13714 in a novel object pattern separation task

No abstract is available for this paper.

• Publication year

  2015

• Venue

  British Journal of Pharmacology

• Publication date

  2015-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/bph.13071PMID 25572672PMCID PMC4409905
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The object pattern separation (OPS) task: a behavioral paradigm derived from the object recognition task.

  2015cited by this paper
• Loss of pattern separation performance in schizophrenia suggests dentate gyrus dysfunction.

  2014cited by this paper
• Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT(1A) receptor activation.

  2014cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: Enzymes

  2013cited by this paper
• The operation of pattern separation and pattern completion processes associated with different attributes or domains of memory.

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cited by this paper
• Hippocampal neurogenesis and forgetting.

  2013cited by this paper
• Object recognition testing: methodological considerations on exploration and discrimination measures.

  2012cited by this paper
• Radiosynthesis and Preclinical Evaluation of 18F-F13714 as a Fluorinated 5-HT1A Receptor Agonist Radioligand for PET Neuroimaging

  2012cited by this paper
• Neurogenesis and generalization: a new approach to stratify and treat anxiety disorders

  2012influential reference
• Object recognition testing: statistical considerations.

  2012cited by this paper
• EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.

  2012cited by this paper
• Anatomically Selective Serotonergic Type 1A and Serotonergic Type 2A Therapies for Parkinson's Disease: An Approach to Reducing Dyskinesia without Exacerbating Parkinsonism?

  2011cited by this paper
• Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder.

  2011cited by this paper
• Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.

  2011cited by this paper
• Liver X receptor activation restores memory in aged AD mice without reducing amyloid.

  2011cited by this paper
• Biased agonism at serotonin 5-HT 1A receptors: preferential postsynaptic activity for improved therapy of CNS disorders

  2011cited by this paper
• GEBR‐7b, a novel PDE4D selective inhibitor that improves memory in rodents at non‐emetic doses

  2011cited by this paper
• Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines

  2010cited by this paper
• Guidelines for reporting experiments involving animals: the ARRIVE guidelines

  2010cited by this paper
• [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging

  2010cited by this paper
• An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's disease.

  2010cited by this paper
• F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity.

  2010cited by this paper
• Agonist-dependent modulation of G-protein coupling and transduction of 5-HT1A receptors in rat dorsal raphe nucleus.

  2010cited by this paper
• F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonists.

  2010cited by this paper
• A Functional Role for Adult Hippocampal Neurogenesis in Spatial Pattern Separation

  2009cited by this paper
• Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT1A receptor agonist

  2009cited by this paper
• The serotonin-1A receptor in anxiety disorders.

  2009cited by this paper
• The role of 5-HT(1A) receptors in learning and memory.

  2008cited by this paper
• Activation of septal 5‐HT1A receptors alters spatial memory encoding, interferes with consolidation, but does not affect retrieval in rats subjected to a water‐maze task

  2008cited by this paper
• The role of the dentate gyrus, CA3a,b, and CA3c for detecting spatial and environmental novelty

  2008cited by this paper
• Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?

  2008cited by this paper
• Role of 5-HT1A Receptors in Learning and Memory

  2007cited by this paper
• Rapid desensitization of somatodendritic 5‐HT1A receptors by chronic administration of the high‐efficacy 5‐HT1A agonist, F13714: a microdialysis study in the rat

  2006cited by this paper
• Neuropharmacology of 5-hydroxytryptamine.

  2006cited by this paper
• Regional Differences in the Coupling of 5-Hydroxytryptamine-1A Receptors to G Proteins in the Rat Brain

  2006cited by this paper
• 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.

  2004cited by this paper
• Serotonin-Induced Increases in Adult Cell Proliferation and Neurogenesis are Mediated Through Different and Common 5-HT Receptor Subtypes in the Dentate Gyrus and the Subventricular Zone

  2004cited by this paper
• Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration.

  2003cited by this paper
• Is there a role for 5-HT1A agonists in the treatment of depression?

  2003cited by this paper
• Performance of different mouse strains in an object recognition task.

  2003cited by this paper
• Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor Subtypes

  2002cited by this paper
• Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes

  2002cited by this paper
• 5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus.

  2002influential reference
• Pharmacology of rapid-onset antidepressant treatment strategies.

  2001cited by this paper
• Chronic administration of the 5‐HT1A receptor agonist 8‐OH‐DPAT differentially desensitizes 5‐HT1A autoreceptors of the dorsal and median raphe nuclei

  1997cited by this paper
• Possible role of nitric oxide-cyclic GMP pathway in object recognition memory: effects of 7-nitroindazole and zaprinast.

  1997cited by this paper
• A new one-trial test for neurobiological studies of memory in rats. III. Spatial vs. non-spatial working memory.

  1992influential reference
• Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene.

  1990cited by this paper
• A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

  1988cited by this paper
• The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor

  1988cited by this paper
• Simple memory: a theory for archicortex.

  1971cited by this paper
• NEUROPHARMACOLOGY OF 5-HYDROXYTRYPTAMINE

  year unknowncited by this paper

• Activation of the serotonin-1A receptor promotes neural regeneration in the rat model of neonatal hypoxic-ischemic brain damage.

  2026cites this paper
• Role of 5-HT1A and 5-HT7 Receptors in Memory Regulation and the Importance of Their Coexpression: A Systematic Review

  2025cites this paper
• Augmentation Therapy With Serotonin 5‐HT1A Receptor Partial Agonists on Cognitive Function in Depressive Disorders: A Systematic Review of Randomized Controlled Studies

  2025cites this paper
• Rescue of respiratory and cognitive impairments in Rett Syndrome mice using NLX-101, a selective 5-HT1A receptor biased agonist.

  2025cites this paper
• Flibanserin conquers murine depressive pseudodementia by amending HPA axis, maladaptive inflammation and AKT/GSK/STAT/BDNF trajectory: center-staging of the serotonergic/adrenergic circuitry.

  2024cites this paper
• Serotonin 5-HT1A receptor biased agonists: the challenge of translating an innovative neuropharmacological concept into therapeutics.

  2024cites this paper
• Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis

  2023cites this paper
• The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, display ketamine-like RAAD and anti-TRD activities in rat CMS models

  2023cites this paper
• Biased 5-HT1A receptor agonists F13714 and NLX-101 differentially affect pattern separation and neuronal plasticity in rats after acute and chronic treatment.

  2022cites this paper
• NLX-101, a 5-HT1A receptor-biased agonist, improves pattern separation and stimulates neuroplasticity in aged rats.

  2022cites this paper
• The role of serotonin in declarative memory: a systematic review of animal and human research.

  2022cites this paper
• Exercise to spot the differences: a framework for the effect of exercise on hippocampal pattern separation in humans

  2022cites this paper
• Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders.

  2021cites this paper
• The Roles of Serotonin in Neuropsychiatric Disorders

  2021cites this paper
• NLX-101, a cortical 5-HT1A receptor biased agonist, reverses scopolamine-induced deficit in the delayed non-matching to position model of cognition.

  2021cites this paper
• Biased agonism in drug discovery: Is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases?

  2021cites this paper
• The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress

  2021cites this paper
• Improving cognitive functioning in major depressive disorder with psychedelics: a dimensional approach.

  2021cites this paper
• Perspectives for therapy of treatment‐resistant depression

  2021cites this paper
• Discriminative stimulus properties of the 5-HT1A receptor biased agonists NLX-101 and F13714, in rats trained to discriminate 8-OH-DPAT from saline

  2021cites this paper
• The spontaneous location recognition task for assessing spatial pattern separation and memory across a delay in rats and mice

  2021cites this paper
• Phosphodiesterase inhibitors roflumilast and vardenafil prevent sleep deprivation‐induced deficits in spatial pattern separation

  2020cites this paper
• NLX-101, a highly selective 5-HT1A receptor biased agonist, mediates antidepressant-like activity in rats via prefrontal cortex 5-HT1A receptors.

  2020cites this paper
• The 5-HT1A receptor as a serotonergic target for neuroprotection in cerebral ischemia.

  2020cites this paper
• Adult Neural Stem Cells as Promising Targets in Psychiatric Disorders

  2020cites this paper
• Serotonergic control of excitability: from neuron to networks

  2020cites this paper
• A second for the cholinergic system in Alzheimer therapy

  2019cites this paper
• Activation of 5-HT1A postsynaptic receptors by NLX-101 results in functional recovery and an increase in neuroplasticity in mice with brain ischemia.

  2019cites this paper
• From Receptor Selectivity to Functional Selectivity: The Rise of Biased Agonism in 5-HT1A Receptor Drug Discovery.

  2019cites this paper
• Cortical 5-hydroxytryptamine 1A receptor biased agonist, NLX-101, displays rapid-acting antidepressant-like properties in the rat chronic mild stress model

  2019influential citation
• Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT1A Receptor-Biased Agonists with Robust Antidepressant-like Activity.

  2019cites this paper
• Activation of somatodendritic 5-HT1A autoreceptors reduces the acquisition and expression of cued fear in the rat fear-potentiated startle test

  2018cites this paper
• Object Novelty Memory Tests

  2018cites this paper
• Assessing spatial pattern separation in rodents using the object pattern separation task

  2018cites this paper
• Frameworking memory and serotonergic markers

  2017cites this paper
• A second wind for the cholinergic system in Alzheimer’s therapy

  2017cites this paper
• Neural activity, memory, and dementias: serotonergic markers

  2017cites this paper
• Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States

  2016cites this paper
• Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study

  2016cites this paper
• Corticosterone levels and behavioral changes induced by simultaneous exposure to chronic social stress and enriched environments in NMRI male mice.

  2016cites this paper
• α7 nicotinic acetylcholine receptors and memory processes: mechanistic and behavioral studies

  2015cites this paper
• Serotonin, neural markers, and memory

  2015cites this paper